Divi's Laboratories Stock

Divi's Laboratories EBIT Margin

The EBIT Margin (Operating Margin) of Divi's Laboratories (DIVISLAB.NS) as of Jul 26, 2026 is 27.46 %. In the previous year, EBIT Margin (Operating Margin) was 23.34 % — a change of 17.64% (higher).

EBIT Margin

27.46 %

YoY

17.64%

Last updated:

EBIT Margin (Operating Margin) of Divi's Laboratories is 2026 27.46 % . EBIT Margin (Operating Margin) of Divi's Laboratories was 2025 23.34 % . It decreases by 17.64% higher compared to the previous year.

For Divi's Laboratories, the operating (EBIT) margin of 27.5% is down versus 37.5% a few years ago.

Access this data via the Eulerpool API

Divi's Laboratories Stock analysis

What does Divi's Laboratories do? Divi's Laboratories Ltd. is a pharmaceutical company based in Hyderabad, India. It was founded in 1990 and has become one of the leading manufacturers of active ingredients and formulations for the pharmaceutical industry in recent years. The company was founded by Dr. Murali Divi, who built the company on principles of quality, technology, and innovation. Divi's Laboratories now employs approximately 13,000 employees and operates production facilities in India and the USA. The company operates in various sectors, including generics, custom synthesis, research and development, and nutraceuticals. Its products are used worldwide and are approved in over 95 countries. Divi's Laboratories follows a vertically integrated supply chain model, producing high-quality active ingredients and developing its own formulations for the pharmaceutical industry. The company always relies on innovative technologies and continuous improvement of product quality. Its product range includes a wide range of active ingredients for various therapeutic areas, such as antibiotics, antidepressants, antihypertensives, antidiabetics, static lipid-lowering agents, and antipsychotics. Divi's Laboratories has state-of-the-art production facilities, strict quality controls, and advanced analytical facilities for all pharmaceutical ingredients. In addition to its active ingredients, the company is also known for its custom synthesis services, which involve the production of customer-specific active ingredients for the pharmaceutical industry. Divi's Laboratories offers a tailored service that meets the specific requirements of customers, ranging from the development of new active ingredients and formulations to the production of small or medium quantities of active ingredients. In the area of research and development, Divi's Laboratories works closely with academic institutions and other pharmaceutical companies to leverage the latest scientific knowledge and develop innovative products. The company invests a significant sum in research and development annually. In addition to active ingredients and custom synthesis services, Divi's Laboratories also offers a range of nutraceuticals. These products, such as vitamins, minerals, and other dietary supplements, are used to support a healthy lifestyle. In summary, Divi's Laboratories is an India-based pharmaceutical company specializing in the manufacture of active ingredients and formulations for the pharmaceutical industry. The company operates to the highest quality standards and relies on innovative technologies and sustainable product development. The wide product range and custom synthesis services offer customers a tailored solution for their needs. Divi's Laboratories is a leading provider of active ingredients and has made a name for itself in the pharmaceutical and nutraceutical industry due to its high quality and productivity. Divi's Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Divi's Laboratories stock

EBIT Margin (Operating Margin) of Divi's Laboratories is 27.46 % in 2026.

Access this data via the Eulerpool API

Margins — Divi's Laboratories

All Key Metrics — Divi's Laboratories